Neuroimaging of mood disorders

Current Opinion in Psychiatry

Volumn 10, Issue 2, 1997, Pages 73-78

  Grasby, Paul M ^a   Bench, Christopher ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRACER;

BEHAVIOR DISORDER; BRAIN FUNCTION; BRAIN MAPPING; COMPUTER ASSISTED TOMOGRAPHY; DEPRESSION; HUMAN; IMAGING; MOOD; NEUROCHEMISTRY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW;

EID: 0030996613     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001504-199703000-00003     Document Type: Review

References (56)

1. Elkis H, Friedman L, Wise A, Meltzer HY: Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Comparisons with controls or patients with schizophrenia. Arch Gen Psychiatry 1995, 52:735 746. Four meta-analytic reviews comparing patients with mood disorders with normal control individuals and schizophrenic patients on ventricular enlargement. Patients with mood disorders have ventricular enlargement and increased sulcal prominence. Ventricular enlargement is less than that seen in schizophrenia.
2. Wurthmann C, Bogerts B, Falkai P: Brain morphology assessed by computer tomography in patients with geriatric depression, patients with degenerative dementia, and normal control subjects. Psychiatry Res Neuroimaging 1995, 61:103 111.
3. Alexopoulos GS, Young RC, Shindledecker RD: Brain computed tomography findings in geriatric depression and primary degenerative dementia. Biol Psychiatry 1992, 31:591 599.
4. Pearison GD, Rabins PV, Kim WS, Speedie LJ, Moberg PJ, Burns A, Bascom MJ: Structural brain CT changes and cognitive deficits in elderly depressives with and without reversible dementia ('pseudodementla'). Psychol Med 1989, 19:573 584.
5. Coffey CE, Wilkinson WE, Weiner RD, Parashos IA, Djang WT, Webb MC, Figiel GS, Spritzer CE: Quantitative cerebral anatomy in depression. Arch Gen Psychiatry 1993, 50:7 16.
6. Steingard RJ, Renshaw PF, Yurgelun-Todd D, Appelmans KE, Lyoo IK, Shorrock KL, Bucci JP, Cesena M, Abebe D, Zurakowski D et al.: Structural abnormalities in brain magnetic resonance images of depressed children. J Am Acad Child Adolesc Psychiatry 1996, 35:307-311. A provocative study that raises the possibility of structural brain changes in young patients with depression. It requires replication in a prospective investigation using automated image analysis procedures.
7. Aylward EH, Roberts-Twillie JV, Barta PE, Kumar AJ, Harris GJ, Geer M, Peyser CE, Pearlon GD: Basal ganglia volumes and white matter hyperintensltles in patients with bipolar disorder. Am J Psychiatry 1994, 151:687 693
8. Husain MM, McDonald WM, Doraiswamy PM, Figiel GS, Na C, Escalona PR, Boyko OB, Nemeroff CB, Krishnan KRR: A magnetic resonance imaging study of putamen nuclei in major depression. Psychiatry Res Neuroimaging 1991, 40:95 99.
9. Krishnan KRR, McDonald WM, Escalona PR, Doraiswamy PM, Na C, Husain MM, Figiel GS, Boyko OB, Ellinwood EH, Nemeroff CB: Magnetic resonance Imaging of the caudate nuclel in depression. Arch Gen Psychiatry 1992, 49:553 557.
10. Hickie I, Hickie C, Scott E, Wilhelm K: Magnetic resonance imaging in primary and secondary depression. In Melancholia. A disorder of movement and mood. Edited by Parker G, Hadzi-Pavlovic D. Cambridge: Cambridge University Press; 1996:252 266. This book is recommended reading for researchers of major depression, particularly those with an interest in psychomotor function and its cerebral correlates. The authors describe the development of the CORE system, a behavioural sign-based approach that facilitates the identification of neurobiologically discrete groups among depressive disorders. It also includes useful literature reviews and a summary of work from the Mood Disorders Unit in Sydney.
11. Beats BC, Sahakian BJ, Levy R: Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed. Psychol Med 1996, 26:591 603.
12. O'Brien JT, Ames D, Schweitzer I, Colman P, Desmond P, Tress B: Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer's disease. Br J Psychiatry 1996, 68:679-687. An attempt to relate hypothalamic-pituitary-adrenalaxis function to depressive symptoms and hippocampal atrophy. The failure to find a relationship with MRI measures may be explained by the qualitative methods of rating. An exciting area of work in affective disorder that brings together researchers from many disciplines.
13. Krishnan KRR: Neuroanatomic substrates of depression in the elderly. J Geriatr Psychiatr Neurol 1993, 6:39 58.
14. Hickie I, Scott E, Mitchell P, Wilhelm K, Austin M-P, Bennett B: Subcortlcal hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 1995, 37:151-160.
15. Greenwald BS, Kramer-Ginsberg E, Krishnan KRR, Ashtari M, Aupperle PM, Patel M: MRI signal hyperintensities in geriatric depression. Am J Psychiatry 1996, 153:1212-1215.
16. Jernigan TL, Press GA, Hesselink JR: Methods for measuring brain morphological features on magnetic resonance images: validation and normal ageing. Arch Neurol 1990, 47:27 32.
17. McDonald WM, Krishnan KRR, Doraiswamy PM, Blazer DG: Occurrences of subcortical hyperintensities in elderly subjects with mania. Psychiatry Res Neuroimaging 1991, 40:211 220.
18. Woods BT, Yurgelun-Todd O, Mikulis D, Pillay SS: Age-related MRI abnormalities in bipolar illness: a clinical study. Biol Psychiatry 1995. 38:846 847.
19. Lesser IM, Boone K, Mehringer M, Wohl MA, Miller BL, Berman NG: Cognition and white matter hyperintensities in older depressed patients. Am J Psychiatry 1996, 153:1280 1287.
20. Dupont RM, Jernigan TL, Heindel W, Butters N, Shafer K, Wilson T, Hesselink J, Gillin JC: Magnetic resonance imaging and mood disorders. Localization of white matter and other subcortical abnormalities. Arch Gen Psychiatry 1995, 52:747 755. One of the few studies to use quantitative MRI to examine younger patients with bipolar and unipolar mood disorders.
21. Dupont RM, Butters N, Schafer K, Wilson T, Hesselink J, Gillin JC: Diagnostic specificity of focal white matter abnormalities in bipolar and unipolar mood disorder. Biol Psychiatry 1995, 38:482 486.
22. Altshuler LL, Curran JG, Hauser P, Mitz J, Denicoff K, Post R: T2 hyperintensities in bipolar disorder: magnetic resonance imaging comparison and literature meta-analysis. Am J Psychiatry 1995, 152:1139 1144. A brief review of the 'hyperintensity' literature, including some methodological pitfalls and some meta-analysis of pooled data. The authors also present their own study in which they differentiated between bipolar I and bipolar II patients. They confirmed increased periventricular hyperintensities in bipolar I patients but found bipolar II to be more similar to normal control individuals.
23. O'Brien J, Desmond P, Ames D, Schweitzer I, Harrigan S, Tress B: A magnetic resonance imaging study of white matter lesions in depression and Alzheimer's disease. Br J Psychiatry 1996, 168:477-485. A well designed study that found associations between depression and deep white matter lesions and between Alzheimer's disease and periventricular lesions after controlling for cardiovascular risk factors, including current blood pressure and age. The study did not have a quantitative MRI methodology.
24. Goodwin GM: Functional Imaging, affective disorder and dementia. Br Med Bull 1996, 52:495 512. An authoritative review chapter in an edition dedicated to 'biological psychiatry'.
25. Sackheim HA, Prohovnik I, Moeller JR, Brown RP, Apter S, Prudic J, Devanand DP, Mukherjee S: Regional cerebral blood flow in mood disorders: I. Comparison of major depressives and normal controls at rest. Arch Gen Psychiatry 1990, 47:60 70.
26. Austin M-P, Dougall N, Ross M, Murray C, O'Carroll RE, Moffoot A, Ebmeier KP, Goodwin GM. Single photon emission tomography with 99mTc-Exametazime in major depression and the pattern of brain activity underlying the psychotic/neurotic continuum. J Affect Disord 1992, 26:31-44.
27. Bench CJ, Fristen KJ, Brown RG, Frackowiak RSJ, Dolan RJ: Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions. Psychol Med 1993, 23:579 590.
28. Goodwin GM, Austin M-P, Dougall N, Ross M, Murray C, O'Carroll RE, Moffoot A, Prentice N, Ebmeier KP: State changes in brain activity shown by the uptake of 99mTc-Exametazime with single photon emission tomography in major depression before and after treatment. J Affect Disord 1993, 29:243 253.
29. Drevets WC, Raichle ME: Neuroanatomical circuits in depression: implications for treatment mechanisms. Psychopharmacol Bull 1992, 28:261 274.
30. Ebert D, Feistel H, Barocka A, Kaschka W: Increased limbic blood flow and total sleep deprivation in major depression with melancholia. Psychiatry Res: Neuroimaging 1994, 55:101 109.
31. Nobler MS, Sackheim HA, Prohovnik I, Moeller JR, Mukherjee S, Schnur DB, Prudic J, Devanand DP: Regional cerebral blood flow in mood disorders III. Treatment and clinical response. Arch Gen Psychiatry 1994, 51:884 897.
32. Bench CJ, Frackowiak RSJ, Dolan RJ: Changes in regional cerebral blood flow on recovery from depression. Psychol Med 1995, 25:247 261. This study documented significant increases of rCBF on clinical recovery in areas previously described as having decreased rCBF in the depressed state. A persisting correlation between medial prefrontal rCBF and impaired cognitive function may serve as a trait marker for depression.
33. Pardo JV, Pardo PJ, Raichle ME: Neural correlates of self-induced dysphoria. Am J Psychiatry 1993, 150:713 719.
34. George MS, Ketter TA, Parekh PI, Horwitz B, Herscovitch P, Post RM: Brain activity during transient sadness and happiness in healthy women. Am J Psychiatry 1995, 152:341 351. A more refined study using a combination of visually presented affect-laden faces and recall of affect-appropriate life events. Activation of limbic and paralimbic cortex and subcortical structures during sadness and reduction in rCBF in right prefrontal and temporoparietal regions during happiness were found.
35. Schneider F, Gur RE, Mozley LH, Smith RJ, Mozley PD, Censits DM, Alavi A, Gur RC: Mood effects on limbic blood flow correlate with emotional self rating: a PET study with oxygen-15 labeled water. Psychiatry Res: Neuroimaging 1995, 61:265 283. The authors showed specific effects of mood on subcortical rather than cortical regions. rCBF increased in left amygdala and decreased in right amygdala during sad mood. The magnitude of changes correlated with negative affect.
36. Schneider F, Gur RE, Alavi A, Seligman MEP, Mozley LH, Smith RJ, Mozley PD, Gur RC: Cerebral blood flow changes in limbic regions induced by unsolvable anagram tasks. Am J Psychiatry 1996, 153:206 212. Further work by the same group using a model of learned helplessness.
37. Adolphs R, Tranel D, Damasio H, Damasio A: Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala. Nature 1994, 372:669-672.
38. Hamann SB, Stefanacci L, Squire LR, Adolphs R, Tranel D, Damasio H, Damasio A Recognizing facial emotion. Nature 1996, 379:497 A case report suggesting that recognition of facial emotion in adults is not absolutely dependent on the amygdala.
39. Ketter TA, Andreason PJ, George MS, Lee C, Gill DS, Parakh PI, Willis MW, Herscovitch P, Post RM: Anterior paralimbic mediation of procaine-induced emotional and psychosensory experiences. Am J Psychiatry 1996, 53:59 69. An important study that uses a pharmacological method to induce mood change. Further studies are likely to follow in groups of patients.
40. Mann JJ, Malone KM, Diehl DJ, Perel J, Nichols TE, Mintun MA: Positron emission tomographic imaging of serotonin activation effects on prefrontal cortex in healthy volunteers. J Cereb Blood Flow Metab 1996, 16:418-426.
41. Mann J, Malone KM, Diehl DJ, Perel J, Cooper TB, Mintun MA: Demonstration In vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiatry 1996, 153:174 182. One of the first well controlled studies to apply a pharmacological challenge strategy to depressed patients. Interesting results, although the numbers are small, as is often the case in neuroimaging studies.
42. Toga AW, Frackowiak RSJ, Mazziota JC: Second internationl conference on functional mapping of the human brain. Neurolmage 1996, 3(Suppl 1): 1-616. A complete book of abstracts from this important conference giving a clear indication of new directions in the field of human brain mapping; a significant role for functional MRI-based techniques is apparent.
43. Kato T, Shioiri T, Murashita J, Hamakawa H, Inubishi T, Takahashi S: Phosphorous-31 magnetic resonance spectroscopy and ventricular enlargement in bipolar disorder. Psychiatry Res: Neuroimaging 1994, 55:41 50.
44. Deicken RF, Fein G, Weiner MW: Abnormal frontal lobe phosphorous metabolism in bipolar disorder. Am J Psychiatry 1995, 152:915 918.
45. Kato T, Shioiri T, Murashita J, Hamakawa H, Takahashi Y. Inubishi T, Takahashi S: Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS. Psychol Med 1995, 25:557 566.
46. Grasby P, Malizia A, Bench C: Psychopharmacology - in vivo neurochemistry and pharmacology. Br Med Bull 1996, 52:513 526 A recent brief review of psychopharmacology imaging.
47. 2 receptor density is indicative of psychosis rather than mood abnormality.
48. 2 receptor SPECT before and after anti-depressant therapy. Psychopharmacology (in press).
49. 2 binding in depression. Psychol Med (in press).
50. 1A receptors in the living human brain.
51. 2 receptor.
52. Bergstrom KA, Hallidin C, Hall H, Akerman K, Kuikka J, Hiltunen J, Lundkvist C, Ginovart N, Swahn C-G, Tiihnen J et al.: Nor-beta-CIT: a potential ligand for visualisation of the serotonin transporter in the human brain. In Preclinical pharmacological studies with and for radiopharmaceuticals. Conference Proceedings. Service Hospitalier Frederic Joliot. Orsay. October 1996.
53. 11C] McN5652. J Cereb Blood Flow Metau 1995, 15:798 805.
54. Schloesser R, Simkowitz P, Bartlett EJ, Wolkin A, Smith GS, Dewey SL, Brodie JD: The study of neurotransmitter interactions using positron emission tomography and functional coupling. Clin Neuropharmacol 1996, 19:371 389. A review of studies in primates and humans of neurotransmitter interactions.
55. Dewey SL, Smith GS, Logan J, Alexoff D, Ding YS, King P, Pappas N, Brodie JD, Ashby CR Jr Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J Neurosci 1995, 15:821 829
56. 2 dopamine receptor binding in humans measured with positron emission tomography. Psychopharmacology 1996, 126:277 280.